- Filed
- Feb 20, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 14, 2025 | 84.85M sh |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $288.31M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $678.91M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $2.13B |
| Current Assets | FY 2024 · Dec 31, 2023 | $1.49B |
| Total Assets | FY 2024 · Dec 31, 2023 | $2.98B |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 87.08M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2022 | $131.99M |
| Capex | FY 2024 · Dec 31, 2022 | $83.22M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | $30.34M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $723.55M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | $0.53 |
| Eps Basic | FY 2024 · Dec 31, 2022 | $0.53 |
| Sga Expense restated | FY 2024 · Dec 31, 2022 | $654.08M |
| Net Income | FY 2024 · Dec 31, 2022 | $45.73M |
| Operating Income restated | FY 2024 · Dec 31, 2022 | $59.34M |
| Gross Profit restated | FY 2024 · Dec 31, 2022 | $785.92M |
| Cost Of Revenue restated | FY 2024 · Dec 31, 2022 | $3.76B |
| Revenue restated | FY 2024 · Dec 31, 2022 | $4.54B |